← Back to Search

Interactive Virtual Workday Training for Autism

N/A
Waitlist Available
Led By Matthew J Smith, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-26 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and posttest (approximately 6 weeks after baseline)
Awards & highlights

Study Summary

This trial proposes to develop and test the effectiveness of a computerized training tool to help nearly 50,000 youth with autism get and keep jobs. It will help them prepare for effective workplace communication, apply social cognitive strategies, and practice simulated conversations.

Who is the study for?
This trial is for young adults aged 18-26 with Autism Spectrum Disorder (ASD) who can read at a 4th-grade level or higher. Participants must either have an ASD diagnosis confirmed by parent report on the Social Responsivity Scale or have an ASD record with MCTI.Check my eligibility
What is being tested?
The 'Work Chat: An Interactive Virtual Workday' tool is being tested to improve workplace communication skills in individuals with ASD. It includes e-learning, simulated conversations using PeopleSim technology, and a virtual workday environment where early actions affect later interactions.See study design
What are the potential side effects?
Since this intervention involves educational and simulation-based training tools rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience frustration or anxiety during challenging simulations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and posttest (approximately 6 weeks after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and posttest (approximately 6 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Emotion Recognition Ability - MiniPONs
Change in Emotion Regulation - Emotion Dysregulation Inventory Short Form (Reactivity Index Short Form)
Change in Managing Emotions
+2 more
Secondary outcome measures
Change in Anxiety
Greater Gains/Change in Workplace Functioning - Workplace Behavior Inventory (WBI)
Other outcome measures
Change in Social Competence/Applied Social Ability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Transition Services + Work ChatExperimental Treatment1 Intervention
This arm will receive services as usual plus the Work Chat intervention over a series of a few weeks. We estimate approximately 15-18 hours of training will occur.
Group II: Standard Transition ServicesActive Control1 Intervention
This arm will receive services as usual.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,782 Previous Clinical Trials
6,364,339 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
1,362 Patients Enrolled for Autism Spectrum Disorder
SIMmersion, LLCIndustry Sponsor
7 Previous Clinical Trials
734 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
161 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,099 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,043 Patients Enrolled for Autism Spectrum Disorder

Media Library

Autism Spectrum Disorder Research Study Groups: Standard Transition Services + Work Chat, Standard Transition Services
Autism Spectrum Disorder Clinical Trial 2023: Standard Transition Services + Work Chat Highlights & Side Effects. Trial Name: NCT05565482 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining opportunities to join this research experiment?

"According to clinicaltrials.gov, this study is not presently recruiting patients; the trial was first announced on October 13th and last updated a few weeks later on Halloween day. Unfortunately, no new enrollees are necessary at present, though 280 other medical trials do remain open for individuals seeking treatment currently."

Answered by AI

What are the ambitions of this scientific investigation?

"This clinical trial's chief objective, which will be assessed during baseline and posttest (approximately 6 weeks later), is to foster a greater degree of sustained employment for participants over 9 months. Secondary outcomes comprise alteration in perceived social self-efficacy via the 5-item Perceived Social Self-Efficacy Scale (PSSE) ranging from 1 ("Not at all well") to 5 ("Very well"), with total possible scores between 5 and 25; modification in empathy self-efficacy through the 6-item Perceived Empathy Self Efficacy Scale (PESE) ranging from 1 ("Not at all well") to 5 ("Very"

Answered by AI
~78 spots leftby Oct 2024